Ovarian hormones organize and activate neural circuits for reproduction and may also mediate cognition. Research has focused on estradiol's mnemonic effects, albeit progesterone covaries with estradiol and its mechanisms for cognition require attention. Studies tested the hypothesis that cognitive effects of progesterone occur subsequent to its metabolism to 5a-pregnan-3a-ol-20-one (3a,5a-THP), which does not bind progestin receptors. Cognitive performance and progestogen levels in plasma, hippocampus, and cortex were determined in ovariectomized mice administered vehicle, or progestins that differentially form 3a,5a-THP and bind progestin receptors (progesterone, 3a,5a-THP, and/or medroxyprogesterone acetate). Only treatments that increased 3a,5a-THP levels during memory consolidation (progesterone, 3a,5a-THP, 3a-5a-THP plus medroxyprogesterone acetate, but not progesterone plus medroxyprogesterone acetate) improved cognitive performance. Thus, formation of 3a,5a-THP may be required for progesterone's cognitive-enhancing effects. NeuroReport Effects of vehicle, medroxyprogesterone acetate (MPA), MPA plus progesterone (P 4 ) and MPA + 3a,5a-THP for performance in the object recognition, water maze, conditioned contextual, and cued fear tasks. *P < 0.05; **P < 0.10.
Introduction
Ovarian hormones, such as estradiol and progesterone, are known for their role in organizing and activating neural circuits related to reproduction, but there is emerging evidence for their role in cognitive processes across the lifespan. For example, women are twice as likely as are men to develop Alzheimer's disease [1] . Among younger individuals, differences in cognitive performance have been noted with variations in hormonal milieu (e.g. pregnancy) [2, 3] . There has been considerable interest in the effects of age-related decline in these hormones for cognition, and whether deficits can be ameliorated with their replacement. Despite evidence from animal models that ovarian hormones can benefit cognitive performance [4] [5] [6] [7] , the data on whether hormone therapies reduce risk of cognitive decline with aging are controversial. Synthetic estradiol/progestin (medroxyprogesterone acetate; MPA) therapies (e.g. PremPro; Wyeth, Philadelphia, Pennsylvania, USA) may not be beneficial [8] , and increase risk for Alzheimer's disease and stroke [9, 10] . However, PremPro improved memory and attention in a younger population of women in another study [11] . Women receiving synthetic estradiol and micronized progesterone had better encoding, consolidation, and retrieval in verbal memory tasks [12] . It must be noted that the focus in these studies has been on estradiol, but progesterone naturally covaries with estradiol and its mechanisms for cognition are largely unknown. Understanding how progesterone influences cognitive performance is important for gaining insight into the neurobiology of learning and memory.
A question that needs to be addressed to further understand the role of hormones for cognition is why there is heterogeneity in the responses of individuals to progestins for cognitive performance. Differences in responses may be related to the divergent mechanisms of action of progestins. Although progesterone and MPA bind progestin receptors, they differ in their actions at androgen [13] and glucocorticoid [14] receptors. The effects of progesterone to improve cognitive performance may not rely upon actions at cognate progestin receptors. When progesterone is administered, both progestin receptor-replete mice, and those with lifelong depletion of progestin receptors, have improved performance across several cognitive tasks, compared with that seen with vehicle/placebo [15] . Progesterone and MPA also differ in their ability to be metabolized to 5a-pregnan-3a-ol-20-one (3a,5a-THP), a progestin that does not bind progestin receptors. MPA inhibits the enzyme 3a-hydroxysteroid dehydrogenase, and decreases formation of 3a,5a-THP [16] . Progesterone is a precursor for 3a,5a-THP, and can augment estradiol's effects to enhance formation of 3a5a-THP. Thus, some cognitive effects of progesterone may occur subsequent to metabolism to 3a,5a-THP, and its actions independent of progestin receptors.
To address mechanisms by which progestins exert mnemonic effects, we investigated acute effects on cognitive performance of female mice administered progestins that differentially form 3a,5a-THP and bind progestin receptors. We compared the effects of progesterone, 3a,5a-THP, and/or MPA on cognitive performance of ovariectomized mice, and measured levels of progestins in plasma and putative brain targets (cortex, hippocampus). We hypothesized that mnemonic effects of progesterone occur subsequent to its metabolism to 3a,5a-THP, which does not bind progestin receptors.
Methods
Methods were approved by the Institutional Animal Care and Use Committee at University at Albany and carried out using measures to minimize pain or discomfort (NIH Guide for the Care and Use of Laboratory Animals, #80- 23, 1996) .
Animals and housing
Female mice (C57BL/6UA; N = 71) were obtained from our breeding colony at University at Albany. All mice (adults, 8 weeks old) were ovariectomized under sodium pentobarbital anesthesia (80 mg/kg, intraperitoneal injection) and started in the testing protocol 1 week later. Mice were group housed (4-5/cage) on a reversed 12/12 h light/dark cycle (lights on 08:00 h) with continuous access to rodent chow and tap water.
Hormone treatments
Mice were randomly assigned to treatment conditions, and grouping was counterbalanced across cages and two cohorts. In Experiment 1, the role of 3a,5a-THP was determined by comparing effects of subcutaneous administration of vehicle (vegetable oil, 20% DMSO), progesterone (4 mg/kg; Steraloids, Newport, Rhode Island, USA), and 3a,5a-THP (4 mg/kg; Sigma, St Louis, Missouri, USA). In Experiment 2, the effects of MPA, and whether MPA can block effects of progesterone and 3a,5a-THP were determined by comparing vehicle, MPA (10 mg/kg; Sigma), progesterone plus MPA, and 3a,5a-THP plus MPA. The dosing used was based upon earlier and pilot studies [4, 17] . All treatments were administered immediately posttraining, during consolidation [4] , and levels of progestogens at this time were verified.
Procedure
Mice were screened for normative motor and speciestypical behavior (grooming, nest building, huddling with cagemates), and sensory responses, and visually inspected for good general health (fur, whiskers, posture, gait, muscle tone) before inclusion in the study [4] . Mice were trained and tested in each of the tasks described below once per week. Behavioral data was collected by an observer uninformed of the coded treatment conditions of mice, using automated tracking systems (Any-Maze for object recognition/placement, water maze; San Diego Instruments Freeze Monitor for conditioned fear; San Diego Instruments, San Diego, California, USA).
Object recognition and object placement
Mice were trained with two novel objects placed in an open field (46 Â 57 Â 35 cm) in a single 3-min trial [17] . Four hours later, mice were tested for object recognition and object placement memory. For testing, the percentage of time mice spent exploring a novel (object recognition) or displaced (object placement) object, as a function of total time exploring both objects during the 3-min trial, was calculated. Mice were tested in these tasks with different objects to minimize potential for test decay effects [17] .
Water maze
Mice were habituated to the water maze (San Diego Instruments; 97 cm diameter, 23-251C, water made opaque with white tempera paint) for 60 s. Mice were given 12, 1-min trials, which were organized into three blocks of four trials. Mice were randomly placed in one of the four starting positions in the maze during these trial blocks. Mice were tested in a 60-s probe trial 1 h later, where the time spent in the quadrant where the platform had been located during training was recorded as an index of memory in this task [4] .
Conditioned contextual/cued fear
Mice were habituated to the conditioning chamber for 4 min. During training, a 10-s tone was sounded, immediately followed by a footshock (2 s, 0.35 mA). Mice received tone-shock pairings in three consecutive training trials. Twenty-four hours later, mice were tested for contextual and cued conditioning as determined by time spent freezing to these stimuli over 8, 1-min trials [4] .
Tissue collection/radioimmunoassay
Some mice were readministered treatments, and trunk blood and whole brains were collected after cervical subluxation/decapitation, so that progestogen levels during consolidation could be determined by radioimmunoassay of plasma, cortex and hippocampus [5, 17] .
Data analyses
One-way analyses of variance, with Fisher's post-hoc tests were used, with an a level of P value less than 0.05 for significance, and P value less than 0.10 for a trend.
Results
Experiment 1: Progesterone and 3a,5a-THP enhance cognitive performance, and increase plasma, cortical, and hippocampal 3a,5a-THP levels Posttraining, subcutaneous administration of progesterone or 3a,5a-THP, but not vehicle, significantly increased the percentage of time mice spent exploring the novel object in the object recognition task [F(2,52) = 4.19, P < 0.02; Fig. 1, top left] . However, in the object placement task, there were no differences across groups in the percentage of time spent exploring the displaced object (P = 0.83, vehicle: 57.5 ± 3.4, progesterone: 55.7 ± 3.3, 3a,5a-THP: 59.2 ± 4.8). In the water maze, progesterone or 3a,5a-THP, compared with vehicle, significantly decreased latencies to reach the platform quadrant [F(2,26) = 4.93, P < 0.01; Fig. 1, bottom left] . In the conditioned fear paradigm, progesterone and 3a,5a-THP, compared with vehicle, tended to, and significantly increased, time spent freezing in the context and cued tests, respectively [F(2,26) = 2.85, P < 0.08; F(2,26) = 4.52, P < 0.02; Fig. 1, right] . (Table 1 ). Experiment 2: Medroxyprogesterone acetate alone, or with progesterone, fails to enhance cognitive performance or increase plasma, cortical, and hippocampal 3a,5a-THP levels Posttraining 3a,5a-THP plus MPA significantly increased the percentage of time mice spent exploring the novel object in the object recognition task, compared with vehicle, MPA, or progesterone plus MPA [F(3,71) = 2.66, P < 0.05; Fig. 2, top left ]. Yet, in the object placement task, there were no differences among groups in the percentage of time mice spent exploring the displaced object (P = 0.55; vehicle: 49. 8 (Table 1 ).
Discussion
Results support our hypothesis that progesterone's cognitive-enhancing effects may be because of actions of 3a,5a-THP in the cortex and hippocampus. Treatments that increased 3a,5a-THP levels during memory consolidation (progesterone, 3a,5a-THP, or 3a-5a-THP plus MPA) improved performance in the water maze, object recognition, and conditioned fear tasks, compared with vehicle. Thus, formation of 3a,5a-THP in the hippocampus and cortex may be essential for some of progesterone's mnemonic effects.
The present results contribute to the growing literature on the influence of ovarian hormones for the neurobiology of learning and memory. These results show that progesterone, but not MPA, improve cognitive performance when administered posttraining. These data suggest that different mechanisms of action of progestins may underlie their mnemonic effects. Progesterone and MPA both bind progestin receptors, whereas MPA binds androgen and glucocorticoid receptors. Interestingly, progesterone, but not MPA, protects hippocampal neurons in culture against glutamate toxicity [18] , and can prevent neuronal loss in the hilus of rats injected with kainic acid [19] . Progesterone, but not MPA, reduces spatial learning deficits following cerebral edema of male rats [20] . Progesterone alone reduces brain inflammation and enhances functional recovery of mice following ischemia [21] . These data substantiate further investigation of whether there are actions at divergent receptor targets underlying the beneficial effects of progestins in the central nervous system.
The present results suggest that progestins may improve cognitive performance, in part, subsequent to conversion to 3a,5a-THP. First, similar effects were found in mice administered progesterone and 3a,5a-THP (which both increased 3a,5a-THP levels) to enhance performance in the object recognition, water maze, and conditioned contextual/cued fear tasks. Second, MPA, alone or in conjunction with progesterone, neither improved cognitive performance, nor increased 3a,5a-THP levels. Previously, we have shown in other mouse strains that reduced production of 3a,5a-THP in the hippocampus negatively affects cognitive performance [5, 17] . Age-related decrements in cognitive performance coincides with reduced hippocampal 3a,5a-THP levels among wild-type mice and those with Alzheimer's disease-related pathologies [17] . Third, in this study, progesterone, 3a,5a-THP, or 3a,5a-THP plus MPA enhanced cognitive performance and increased 3a,5a-THP levels in brain areas associated with cognitive tasks. Notably, progesterone and MPA can bind progestin receptors, but 3a,5a-THP does not. Indeed, regimen that enabled 3a,5a-THP formation enhanced cognitive performance, irrespective of their capacity to bind progestin receptors. 3a,5a-THP can have rapid actions at neurotransmitter targets, such as glutamate [22] [23] [24] , that may underlie these effects. Thus, cognitive effects may be independent of progestogens' acute actions at progestin receptors and, instead, involve formation of 3a,5a-THP, and rapid, downstream actions at neurotransmitter targets to initiate signal transduction cascades.
Conclusion
Posttraining administration of the synthetic progestin, MPA, unlike progesterone or 3a,5a-THP, was ineffective in enhancing cognitive performance of young mice or increasing cortical and hippocampal 3a,5a-THP levels during memory consolidation. MPA and progesterone bind progestin receptors, but 3a,5a-THP does not. The beneficial effects of progestins may be independent of intracellular progestin receptors, and subsequent to production of 3a,5a-THP to improve cognitive function. Further investigation of the mechanisms of progestins in the cortex and hippocampus are important for elucidating neurobiological factors underlying sex differences, and age-related decline, in cognitive processes.
